Proterris

0 followers


Proterris, a P2 clinical-stage firm, has pooled a dominant IP position in therapeutic uses of inhaled and small-molecule carbon monoxide.

Industries

Headquarters

Employees

Links

Org chart

Jeffrey Wager

Collapse
Kourosh Saeb-Parsy
Acting Chief Medical Officer
Jim Potenziano
Chief Operating Officer